Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Formulation development of epidermal growth factor.

J Lee1

  • 1Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, USA. jaehwi@pharmacy.purdue.edu

Die Pharmazie
|February 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional analysis of Box II mutations in yeast site-specific recombinases Flp and R. Significance of amino acid conservation within the Int family and the yeast sub-family.

Journal of molecular biology·1992
Same author

Fluorescence study of the ligand stereospecificity for binding to lumazine protein.

European journal of biochemistry·1992
Same author

Reduction of postoperative adhesions in strabismus surgery.

Korean journal of ophthalmology : KJO·1992
Same author

The Red Cross and CDC's natural-disaster surveillance system.

American journal of public health·1992
Same author

Cumulative logit modelling for ordinal response variables: applications to biomedical research.

Computer applications in the biosciences : CABIOS·1992
Same author

The sagittal ramus osteotomy. Stability of fixation with internal miniplates.

International journal of oral and maxillofacial surgery·1992
Same journal

Comparative <i>In Vitro</i> Release Profiling of Brand and Generic Metoprolol Extended-Release Formulations in the Context of Product Switching.

Die Pharmazie·2026
Same journal

The Role of SGLT2 Inhibitors in the Management of Diabetic Retinopathy: A Literature Review.

Die Pharmazie·2026
Same journal

Research Progress on Ferroptosis-Inducing Compounds in Tumor Cells.

Die Pharmazie·2026
Same journal

Mocetinostat Ameliorates Pathological Cardiac Hypertrophy via Suppression of Ferroptosis Through Nrf2 Pathway.

Die Pharmazie·2026
Same journal

Different Effects of the Anticonvulsant Drugs Phenytoin and Phenobarbital on Forskolin-Induced BeWo Syncytialization.

Die Pharmazie·2026
Same journal

MC4R Antagonists: A Promising New Hope for the Treatment of Cachexia and Wasting Diseases.

Die Pharmazie·2026
See all related articles

Researchers are exploring new ways to deliver epidermal growth factor (EGF) for wound healing. Recent focus is on developing controlled delivery systems to improve EGF

Area of Science:

  • Biotechnology and Regenerative Medicine
  • Wound Healing and Tissue Repair

Background:

  • Epidermal Growth Factor (EGF) is a well-characterized polypeptide with significant therapeutic potential.
  • EGF stimulates cellular activities crucial for wound healing and tissue regeneration.
  • Existing delivery methods for EGF are being re-evaluated for optimal therapeutic outcomes.

Purpose of the Study:

  • To summarize recent investigations into epidermal growth factor (EGF) delivery systems.
  • To highlight the importance of EGF in treating wounds and ulcers.
  • To review approaches for optimizing EGF delivery for enhanced wound repair.

Main Methods:

  • Review of recent scientific literature and investigations.
  • Analysis of various EGF delivery strategies.

Related Experiment Videos

  • Focus on the development of sustained and controlled release technologies.

    • Main Results:

    • Multiple approaches have been investigated for EGF delivery to promote wound healing.
    • EGF shows promise in the treatment of diverse wound and ulcer types.
    • Recent research emphasizes controlled and sustained delivery technologies for EGF.

    Conclusions:

    • Epidermal Growth Factor (EGF) delivery systems are critical for effective wound and ulcer treatment.
    • Optimizing EGF delivery through sustained or controlled systems is a key area of current research.
    • Advancements in EGF delivery technology are vital for improving tissue repair processes.